Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LQDA Liquidia Technologies Inc

Trading 02-25 11:10:48 EST

29.86

-3.71

-11.05%

High33.97	Low29.20	Vol2.67M
Open33.87	D1 Closing33.57	Amplitude14.21%
Mkt Cap2.60B	Tradable Cap1.79B	Total Shares87.00M
T/O81.59M	T/O Rate4.45%	Tradable Shares60.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":29.86,"timestamp":1772035837556,"preClose":33.57,"halted":0,"volume":2671926,"delay":0,"changeRate":-0.11051534107834378,"floatShares":60054376,"shares":86995483,"eps":-1.452333,"marketStatus":"Trading","change":-3.71,"latestTime":"02-25 11:10:48 EST","open":33.87,"high":33.9719,"low":29.2,"amount":81587682.574308,"amplitude":0.142148,"askPrice":29.94,"askSize":154,"bidPrice":29.86,"bidSize":143,"shortable":0,"etf":0,"ttmEps":-1.452333,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1532577600000,"exchange":"NASDAQ","adjPreClose":33.57,"preHourTrading":{"tag":"盘前","latestPrice":34.1,"preClose":33.57,"latestTime":"09:15 EST","volume":1955,"amount":66609.91544,"timestamp":1772028910453,"change":0.53,"changeRate":0.015788,"amplitude":0.017873},"postHourTrading":{"tag":"盘后","latestPrice":34.48,"preClose":33.57,"latestTime":"19:54 EST","volume":19306,"amount":648638.4617,"timestamp":1771980867043,"change":0.91,"changeRate":0.027108,"amplitude":0.028299},"volumeRatio":5.76313,"impliedVol":1.758,"impliedVolPercentile":0.9522},"requestUrl":"/m/hq/s/LQDA/wiki","defaultTab":"wiki","newsList":[{"id":"2609513071","title":"Surging Revenue And Technical Momentum Could Be A Game Changer For Liquidia (LQDA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609513071","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609513071?lang=en_us&edition=fundamental","pubTime":"2026-02-06 22:09","pubTimestamp":1770386987,"startTime":"0","endTime":"0","summary":"Recently, Liquidia Corp was identified as meeting the Minervini Trend Template, reflecting strong technical momentum alongside very large year-over-year revenue growth and upgraded analyst revenue forecasts.\nThis combination of exceptional top-line expansion and positive revisions has positioned Liquidia as a market leader in its niche, attracting heightened investor attention even as volatility remains elevated.\nNext, we will explore how Liquidia’s very large revenue growth and upgraded...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/surging-revenue-and-technical-momentum-could-be-a-game-chang","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/surging-revenue-and-technical-momentum-could-be-a-game-chang","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LQDA"],"gpt_icon":0},{"id":"2606787670","title":"Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2606787670","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606787670?lang=en_us&edition=fundamental","pubTime":"2026-01-27 21:30","pubTimestamp":1769520600,"startTime":"0","endTime":"0","summary":"MORRISVILLE, N.C., Jan.  27, 2026  (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA),a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular disea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/27/3226498/0/en/Liquidia-to-Present-Clinical-Data-Across-Its-Portfolio-at-the-Pulmonary-Vascular-Research-Institute-2026-Annual-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","LU0208291251.USD","LU1989772923.USD","LU0256863811.USD","BK4161","BK4580","LU0320765489.SGD","LU0070302665.USD","LU0417517546.SGD","LU1988902786.USD","LU2264538146.SGD","BK4588","PH","LU1989772840.SGD","LU0256863902.USD","BK4585","LU1064131342.USD","BK4007","LU0211331839.USD"],"gpt_icon":0},{"id":"2604133326","title":"How Yutrepia’s Early Traction and Milestones At Liquidia (LQDA) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2604133326","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604133326?lang=en_us&edition=fundamental","pubTime":"2026-01-19 17:12","pubTimestamp":1768813925,"startTime":"0","endTime":"0","summary":"Liquidia Corporation recently presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, highlighting updates on its pulmonary hypertension franchise, including lead drug Yutrepia.\nInvestor commentary points to Yutrepia’s early commercial traction and milestone progress, helped by its delivery and tolerability advantages over existing therapies, as a key driver of renewed attention on Liquidia.\nWe’ll now examine how Yutrepia’s early sales momentum and clinical...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/how-yutrepias-early-traction-and-milestones-at-liquidia-lqda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/how-yutrepias-early-traction-and-milestones-at-liquidia-lqda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2604091343","title":"Liquidia Technologies call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2604091343","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604091343?lang=en_us&edition=fundamental","pubTime":"2026-01-17 02:05","pubTimestamp":1768586712,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Liquidia (LQDA) Technologies with 55,048 calls trading, 9x expected, and implied vol increasing over 18 points to 1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-technologies-call-volume-above-normal-and-directionally-bullish-thefly-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-technologies-call-volume-above-normal-and-directionally-bullish-thefly-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"1185941785","title":"Stock Track | Liquidia Technologies Inc (LQDA) Soars 5.01% as Jefferies Raises Target Price to $55","url":"https://stock-news.laohu8.com/highlight/detail?id=1185941785","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185941785?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:00","pubTimestamp":1768402836,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc (LQDA) saw its stock price surge by 5.01% during the intraday trading session, reflecting strong investor confidence. The upward movement was driven by a positive analyst...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LQDA"],"gpt_icon":0},{"id":"2603713658","title":"Liquidia Chief Human Resource Officer Sarah Krepp Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603713658","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603713658?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:37","pubTimestamp":1768340250,"startTime":"0","endTime":"0","summary":"Sarah Krepp, Chief Human Resource Officer of Liquidia Corporation, reported a disposal of common shares of Liquidia Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liquidia Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL48f6wL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Liquidia Chief Human Resource Officer Sarah Krepp Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2603658105","title":"Liquidia Corporation Files Initial Beneficial Ownership Statement for Chief Development Officer Sanjeev Khindri","url":"https://stock-news.laohu8.com/highlight/detail?id=2603658105","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603658105?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:31","pubTimestamp":1768339870,"startTime":"0","endTime":"0","summary":"Liquidia Corporation has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Sanjeev Khindri, Chief Development Officer of Liquidia, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liquidia Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDLbhzdYv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Liquidia Corporation Files Initial Beneficial Ownership Statement for Chief Development Officer Sanjeev Khindri","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"1176340606","title":"Stock Track | Liquidia Technologies Inc Soars 5% Intraday as Jefferies Raises Target Price to $55","url":"https://stock-news.laohu8.com/highlight/detail?id=1176340606","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176340606?lang=en_us&edition=fundamental","pubTime":"2026-01-14 04:16","pubTimestamp":1768335376,"startTime":"0","endTime":"0","summary":"Liquidia Technologies Inc (LQDA) saw its stock price surge by 5.00% during intraday trading on Tuesday, outperforming the broader market.The sharp rise follows Jefferies' decision to raise its target...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LQDA"],"gpt_icon":0},{"id":"2603352756","title":"Liquidia Corp : Jefferies Raises Target Price to $55 From $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2603352756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603352756?lang=en_us&edition=fundamental","pubTime":"2026-01-13 23:55","pubTimestamp":1768319705,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE0UB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2603356507","title":"Liquidia Price Target Maintained With a $49.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2603356507","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603356507?lang=en_us&edition=fundamental","pubTime":"2026-01-13 17:57","pubTimestamp":1768298220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LQDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2026 04:57 ET (09:57 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2602587589","title":"Is It Too Late To Reassess Liquidia (LQDA) After Its Sharp Share Price Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602587589","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602587589?lang=en_us&edition=fundamental","pubTime":"2026-01-10 18:25","pubTimestamp":1768040704,"startTime":"0","endTime":"0","summary":"If you are wondering whether Liquidia's share price still offers value after a strong run, the starting point is understanding how its current market price lines up with different ways of estimating worth.\nLiquidia's stock closed at US$35.86, with returns of 14.2% over the past week, 9.7% over the past month and 14.2% year to date, while the 1 year return sits at 194.2% and the 3 year return is very large.\nRecent attention on Liquidia has centered on its position in pharmaceuticals and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/is-it-too-late-to-reassess-liquidia-lqda-after-its-sharp-sha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/is-it-too-late-to-reassess-liquidia-lqda-after-its-sharp-sha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LQDA","DCF","BK4007"],"gpt_icon":0},{"id":"2602837786","title":"Liquidia falls -6.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602837786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602837786?lang=en_us&edition=fundamental","pubTime":"2026-01-09 23:05","pubTimestamp":1767971142,"startTime":"0","endTime":"0","summary":"Liquidia (LQDA) is down -6.5%, or -$2.08 to $29.68. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-falls-6-5-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-falls-6-5-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2602320545","title":"Liquidia Reports Preliminary 2025 YUTREPIA Net Sales of $148.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2602320545","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602320545?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:30","pubTimestamp":1767958214,"startTime":"0","endTime":"0","summary":"Liquidia Corporation announced preliminary, unaudited net product sales of approximately $90.1 million for YUTREPIA  inhalation powder in the fourth quarter of 2025 and $148.3 million for the full year 2025. Since its commercial launch in June 2025, YUTREPIA has received more than 2,800 unique patient prescriptions. The company reported generating more than $30 million in positive cash flow during the fourth quarter of 2025. These results reflect the commercial launch of YUTREPIA for both pulmonary arterial hypertension  and pulmonary hypertension associated with interstitial lung disease  patient populations. Liquidia plans to report fully audited financial results for the year ended December 31, 2025, in February 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL4vnL9D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2210149790.SGD","SG9999014005.SGD","BK4112","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LQDA","BK4588","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014039.USD","BK4585","LU2095319765.USD","SG9999014021.USD","NDAQ"],"gpt_icon":0},{"id":"2602732051","title":"Liquidia FY Revenue USD 148.3 Million VS. Ibes Estimate USD 71.9  Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2602732051","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602732051?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:30","pubTimestamp":1767958204,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nPLX1B1CB1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2602378812","title":"Corrected -Liquidia FY Preliminary Net Product Sales From Yutrepia USD 148.3 Million (Adds Dropped Product Name, Removes Reference to Estimate)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602378812","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602378812?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:30","pubTimestamp":1767958204,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nPLX1B1CB1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2601870737","title":"Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601870737","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601870737?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:00","pubTimestamp":1767787200,"startTime":"0","endTime":"0","summary":"MORRISVILLE, N.C., Jan.  07, 2026  (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 44th Annual J.P. Morgan He","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/07/3214399/0/en/Liquidia-Corporation-to-Present-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","LU0971096721.USD","LU1668664300.SGD","LU0158827781.USD","LU0528227936.USD","LU0158827948.USD","LU1363072403.SGD","LU1720051017.SGD","BK4534","BK4007","LU0128526141.USD","LU1720051108.HKD","LU0029874061.USD","BK4585","LU0006306889.USD","LU0106831901.USD","LU0234570918.USD","IE00BKVL7J92.USD","LU0267386448.USD","LU0912757837.SGD","HCSG","LU0098860793.USD","BK4127","LU1732799900.SGD","LU2111349929.HKD","LU0882574139.USD","BK4516","LU1791710582.SGD","LU2023251221.USD","LU0795875169.SGD","LU1074936037.SGD","LU1989772923.USD","LQDA","LU1791710400.SGD","LU0320765646.SGD","BK4581","LU1244550494.USD","LU2028103732.USD","XLV","LU1548497426.USD","LU1162221912.USD","LU0106261372.USD","LU1244550577.SGD","LU2089284900.SGD","IE00BZ1G4Q59.USD","LU2271345857.HKD","LU0557290698.USD","LU0314104364.USD","LABU"],"gpt_icon":0},{"id":"2594290690","title":"Liquidia Price Target Maintained With a $49.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2594290690","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594290690?lang=en_us&edition=fundamental","pubTime":"2025-12-27 01:57","pubTimestamp":1766771820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LQDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 26, 2025 12:57 ET (17:57 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":0},{"id":"2591725256","title":"Is It Too Late To Consider Liquidia After Its 182.6% 2025 Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591725256","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591725256?lang=en_us&edition=fundamental","pubTime":"2025-12-16 08:33","pubTimestamp":1765845238,"startTime":"0","endTime":"0","summary":"If you are wondering whether Liquidia is still a smart buy after its huge run, you are not alone. This is exactly the kind of stock where valuation really matters.\nThe share price has pulled back about 2.3% over the last week, but it is still up 21.9% over 30 days and 182.6% year to date, with a 210.0% gain over the past year and 992.3% over five years.\nThose moves have been driven by growing optimism around Liquidia's pipeline and regulatory progress, with investors reacting positively to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/is-it-too-late-to-consider-liquidia-after-its-1826-2025-surg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/is-it-too-late-to-consider-liquidia-after-its-1826-2025-surg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","LQDA","DCF"],"gpt_icon":0},{"id":"2586729034","title":"A Fresh Look at Liquidia (LQDA) Valuation After Strong Share Price Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2586729034","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586729034?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:34","pubTimestamp":1764081256,"startTime":"0","endTime":"0","summary":"Liquidia (LQDA) shares have been trending steadily higher over the past month, outpacing the broader biotech sector. The climb has caught the attention of investors who are looking for momentum plays in innovative healthcare names.\nSee our latest analysis for Liquidia.\nLiquidia’s impressive move this past month, with a 33.5% share price return, builds on robust momentum that has been gathering steam all year. In fact, the company’s year-to-date share price return has surged 146.9%, and those...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/a-fresh-look-at-liquidia-lqda-valuation-after-strong-share-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/a-fresh-look-at-liquidia-lqda-valuation-after-strong-share-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK4007","LQDA"],"gpt_icon":0},{"id":"2584192587","title":"Liquidia LIQUIDIA Q3 EPS USD -0.04 VS. IBES ESTIMATE USD -0.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2584192587","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584192587?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:25","pubTimestamp":1763569532,"startTime":"0","endTime":"0","summary":"Nov 03 (Reuters) - Liquidia Q3 operating income USD 1.767 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 03-NOV-202511:30:46.023 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD8FCsYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":-0.008},{"period":"1month","weight":-0.1729},{"period":"3month","weight":0.0583},{"period":"6month","weight":0.2225},{"period":"1year","weight":1.1126},{"period":"ytd","weight":-0.0267}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.081499},{"month":2,"riseRate":0.75,"avgChangeRate":0.050315},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.044853},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.072031},{"month":5,"riseRate":0.857143,"avgChangeRate":0.14078},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.074968},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.00324},{"month":8,"riseRate":0.5,"avgChangeRate":0.048271},{"month":9,"riseRate":0.375,"avgChangeRate":0.049793},{"month":10,"riseRate":0.625,"avgChangeRate":0.025896},{"month":11,"riseRate":0.75,"avgChangeRate":0.074904},{"month":12,"riseRate":0.75,"avgChangeRate":0.150821}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction